Clinical software developer PhaseV is teaming up with another global CRO, unveiling a plan to infuse its trial design platform into Bioforum’s services. PhaseV’s Trial Optimizer uses machine learning ...
ConcertAI, which specializes in software and real-world evidence for clinical trials, has unveiled the latest version of its clinical trial optimization product. Dubbed CTO 2.0, the latest version ...
New drugs take too long to get to market because of clinical trial bottlenecks. Two cancer doctors built AI-enabled tech to speed up the process. As longtime cancer doctors with regulatory experience, ...
ConcertAI and NeoGenomics (NASDAQ: NEO) announce a joint software-as-a-service solution in hematological malignancies for research analytics, clinical trial design, and clinical trial operational ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results